News

Need something for here

Current News

Schulman Bhattacharya Successfully Defends Famed Investment Banker; Quashes Series of Subpoenas Aimed at Obtaining his Personal, Private Information

A famed, foreign investment banker retained Schulman Bhattacharya after a series of third-party providers, including Google, Microsoft, and LinkedIn, received subpoenas demanding production of the bankers’ emails, browsing history, payment details, and other invasive personal and business information.  The subpoenas were issued as part of far-reaching discovery in a case currently pending in the United States District Court for the Southern District of New York and sought to drag the banker into the heart of that case.  Schulman Bhattacharya faced... Read More »

Schulman Bhattacharya Engaged to Represent Hormuud Telecom in U.S. Defamation Cases and United Nations Disputes

Hormuud Telecom, the largest telecom company in Somalia and the country’s largest employer and taxpayer, has engaged Schulman Bhattacharya to defend its interests in contentious disputes with various U.S.-based media organizations and the United Nations.  Commenting on the engagement, Jeremy W. Schulman, the Firm’s Managing Member, stated:  “We are pleased to be representing one of the most vital companies in East Africa, helping to protect its legal rights and interests and clearing its name of scurrilous allegations intended to hamper... Read More »

Schulman Bhattacharya Continues Rapid Growth—Famed Corporate Lawyer and Executive Joins the Firm, Along with Experienced Commercial Litigator

Schulman Bhattacharya, LLC is proud to announce the hiring of two new attorneys who will be resident in the Firm’s Washington-area headquarters office.  Jamie Karson joins the firm as Of Counsel.  Jake Schaller arrives as an Associate. Jamie Karson is the former Chief Executive Officer and Chairman of the Board of Steve Madden Ltd. (NASDAQ: “SHOO”), one of the most iconic footwear brands in the world.  During his tenure at the helm of Steve Madden, the company’s market capitalization reached... Read More »

Schulman Bhattacharya Files Sixteen Count Federal Class Action Lawsuit Against Distributors of VSL#3 Probiotic Product–Named Plaintiff-Victims from Massachusetts, California, Texas, New Jersey, Michigan, Illinois, Washington, Florida, and Idaho

On July 23, 2019, Schulman Bhattacharya commenced a class action lawsuit against the U.S. licensor (VSL Pharmaceuticals, Inc.) and distributors (Alfasigma USA, Inc. and Leadiant Biosciences, Inc.) of the VSL#3 probiotic product.  Our complaint, which was filed in the United States District Court for the District of Maryland, asserts sixteen cause of action on behalf of a nationwide class of victims who purchased VSL#3 since June 2016, as well as consumers in subclasses in Massachusetts, California, Texas, New Jersey, Michigan,... Read More »

Federal Judge Upholds $18 Million Jury Verdict in Favor of Schulman Bhattacharya’s Clients, Enters Broad Permanent Injunction to Block Further False Advertising of the VSL#3 Product

In 54 pages of rulings issued this past Friday, June 21, 2019, Judge Theodore D. Chuang of the United States District Court for the District of Maryland found decisively in favor of Schulman Bhattacharya’s clients—Professor Claudio De Simone and ExeGi Pharma, LLC—upholding our $18 million jury verdict from November 2018 and entering a permanent injunction against the current and former distributors of VSL#3, halting their false advertising of the product.  The rulings conclude over four years of litigation in which... Read More »

Schulman Bhattacharya Prevails After Filing California Federal Court Action—Major Internet Commerce Companies Yield to Demand to Block On-Line Sales Transactions for VSL#3 Product

In Schulman Bhattacharya’s ongoing battle over the VSL#3 probiotic product, the Firm successfully resolved a contentious dispute between its client, ExeGi Pharma, LLC, and a group of companies in California that were facilitating the processing of online sales transactions for VSL#3.  The e-commerce companies in question are Nexternal Solutions, Inc., True Commerce, Inc., and HighJump Software, Inc.  Last November, the Firm prevailed before a jury in Maryland federal court and then obtained a judgment holding that the VSL#3 product was... Read More »

Schulman Bhattacharya Wins Attorney’s Fees Challenge in New York Federal Court for Client Benihana of Tokyo

In a 19-page written decision released today, Judge Engelmayer of the United States District Court for the Southern District of New York sided with the Firm and its client, Benihana of Tokyo, LLC, and denied counter-party Benihana Inc.’s petition to vacate a portion of an arbitral award.  The award resulted from a long-running dispute over operation of a Benihana restaurant in Hawaii.  Schulman Bhattacharya was engaged to represent Benihana of Tokyo after the conclusion of the arbitration, which was handled... Read More »

Schulman Bhattacharya in the News: Law Firm Sues to Uphold Rights of Partner in New York Student Housing Project

The Rochester Business Journal and the Daily Record are reporting on our case against real estate developers John Yurtchuk and David Huck, which centers on their breaches of fiduciary duty and other serious misconduct involving a successful student housing project adjacent to the University of Rochester in Rochester, New York.  Schulman Bhattacharya is proud to be representing famed real estate developer Thomas Masaschi in his fight to preserve his ownership interests in the project.  We have a long, successful track... Read More »

National Law Review Reports on Schulman Bhattacharya’s $18 Million Jury Trial Win

Among the many news reports covering our recent trial victory for clients Claudio De Simone and ExeGi Pharma, LLC, the National Law Review ran a story on December 21, 2018 taking an in-depth look at the case, which is shaping up to be one of the leading verdicts in BioTech litigation in 2018.  We are proud to stand with Professor Claudio De Simone and ExeGi Pharma in this fight and will continue to work zealously to protect their product, which... Read More »

Schulman Bhattacharya Wins Major Federal Jury Trial—$18 Million Awarded to Clients Claudio De Simone and ExeGi Pharma for False Advertising, Unjust Enrichment and Unpaid Royalties

A federal jury today in the United States District Court for the District of Maryland unanimously ruled in favor of the Firm’s clients, Claudio De Simone and ExeGi Pharma, LLC, awarding them damages totaling $18,014,041.  De Simone, a renowned Italian inventor and university professor, sued his former business partners as part of a bitter international dispute concerning false advertising, ownership of his proprietary high-potency probiotic formulation, and unpaid royalties. Professor De Simone accused his former partners of making a counterfeit... Read More »